Hepatotoxicity of clozapine

Journal of Clinical Psychopharmacology

Volumn 17, Issue 4, 1997, Pages 314-317

  Hummer, Martina ^a   Kurz, Martin ^a   Kurzthaler, Ilsemarie ^a   Oberbauer, Harald ^a   Miller, Carl ^a   Wolfgang Fleischhacker, W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLOZAPINE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMINE PHENYLPYRUVATE AMINOTRANSFERASE; HALOPERIDOL; LIVER ENZYME;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ANTIPSYCHOTIC AGENTS; ASPARTATE AMINOTRANSFERASES; CLOZAPINE; ENZYMES; FEMALE; HALOPERIDOL; HEPATITIS, TOXIC; HUMANS; LIVER FUNCTION TESTS; MALE; PROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 0030878680     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199708000-00012     Document Type: Article

References (20)

1. Kellner M, Wiedemann K, Krieg JC, Berg PA. Toxic hepatitis by clozapine treatment. Am J Psychiatry 1993;150:985-6.
2. Worrall R, Wilson A, Cullen M. Dystonia and drug-induced hepatitis in a patient treated with clozapine. Am J Psychiatry 1995; 152:647-8.
3. Eggert AE, Crismon ML, Dorson PG, Taylor RL. Clozapine rechallenge after marked liver enzyme elevation. J Clin Psychopharmacol 1994;14:425-6.
4. Cohen IM, Archer JD. Liver function and hepatic complications in patients receiving chlorpromazine. JAMA 1955;159:99-101.
5. Dossing M, Andreasen B. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs. Scand J Gastroenterol 1982;17:205-11.
6. Ishak KG, Irey NS. Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 1972;93:283-304.
7. Levinson DF, Simpson GM. Serious nonextrapyramidal adverse effects of neuroleptics: sudden death, agranulocytosis and hepatotoxicity. In: Meltzer HY, ed. Psychopharmacology, the third generation of progress. New York: Raven Press, 1987:1431-6.
8. Sherlock S. Hepatic reactions to drugs. Gut 1979;20:634-8.
9. Bauer D, Gärtner HJ. Wirkungen der Neuroleptika auf die Leberfunktion, das blutbildende System, den Blutdruck und die Temperaturregulation. Pharmacopsychiatry 1983;16:23-9.
10. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989;50:329-38.
11. Safferman A, Lieberman JA, Kane JM, Szymansky S, Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991;17:247-61.
12. Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW. Clozapine-induced transient white blood count disorders. J Clin Psychiatry 1994;55:429-32.
13. Kurz M, Hummer M, Oberbauer H, Fleischhacker WW. Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology 1995;118:52-6.
14. Hummer M, Sperner-Unterweger B, Kemmler G, Falk M, Kurz M, Oberbauer H, Fleischacker WW. Does eosinophilia predict clozapine induced neutropenia. Psychopharmacology (Berl) 1996; 124:201-1.
15. Haring C, Neudorfer C, Schwitzer J, Hummer M, Saria A, Hinterhuber H, Fleischhacker WW. EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology (Berl) 1994;114:97-100.
16. Gärtner HJ, Fischer E, Hoss J. Side effects of clozapine. Psychopharmacology (Berl) 1989;99:97-100.
17. Marinkovic D, Timotijevic I, Babinski T, Totic S, Paunovic V. The side-effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:537-44.
18. Dölle W, Martini GA. Leber. In: Heintz R, ed. Erkrankungen durch Arzneimittel. Stuttgart, Germany: Thieme, 1978.
19. Haring C, Fleischhacker WW, Schett P, Humpel C, Barnas C, Saria A. Influence of patient-related variables on clozapine plasma levels. Am J Psychiatry 1990;147:1471-5.
20. Jones JK, Van de Carr SW, Zimmermann H, Leroy A. Psychopharmacol Bull 1983;19:24-7.